This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
這位可口可樂分析師以看好的基調開始覆蓋；以下是星期二的五大啓動。
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
頂級華爾街分析師改變了對這些知名公司的看法。有關所有分析師評級變更的完整信息，包括上調、下調和開始覆蓋，請查看我們的分析師評級頁面。
- Piper Sandler analyst Mike Lavery initiated coverage on The Coca-Cola Company (NYSE:KO) with an Overweight rating and announced a price target of $74. Coca-Cola shares closed at $60.81 on Monday. See how other analysts view this stock.
- Truist Securities analyst John McDonald initiated coverage on JPMorgan Chase & Co. (NYSE:JPM) with a Hold rating and announced a price target of $260. JPMorgan shares closed at $240.85 on Tuesday. See how other analysts view this stock.
- RBC Capital analyst Sean Dodge initiated coverage on ICON Public Limited Company (NASDAQ:ICLR) with an Outperform rating and announced a price target of $263. Icon shares closed at $215.51 on Monday. See how other analysts view this stock.
- UBS analyst Eliana Merle initiated coverage on Ascendis Pharma A/S (NASDAQ:ASND) with a Buy rating and announced a price target of $196. Ascendis Pharma shares closed at $140.28 on Monday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Ross Osborn initiated coverage on Anteris Technologies Global Corp. (NASDAQ:AVR) with an Overweight rating and announced a price target of $9. Anteris Technologies shares closed at $5.61 on Monday. See how other analysts view this stock.
- 派傑投資分析師邁克·拉弗裏對可口可樂公司（紐交所：KO）進行了覆蓋，給予了增持評級，並宣佈目標價爲74美元。週一可口可樂股票收於60.81美元。看看其他分析師如何看待這隻股票。
- Truist Securities分析師約翰·麥克唐納對摩根大通Alerian MLP指數ETN（紐交所：JPM）進行了覆蓋，給予了持有評級，並宣佈目標價爲260美元。週二摩根大通股票收於240.85美元。看看其他分析師如何看待這隻股票。
- RBC Capital分析師肖恩·道奇對ICON（納斯達克：ICLR）進行了覆蓋，給予了跑贏大盤評級，並宣佈目標價爲263美元。週一ICON股票收於215.51美元。看看其他分析師如何看待這隻股票。
- 瑞銀分析師埃莉安娜·梅爾對Ascendis Pharma A/S（納斯達克：ASND）進行了覆蓋，給予了買入評級，並宣佈目標價爲196美元。週一Ascendis Pharma股票收於140.28美元。看看其他分析師如何看待這隻股票。
- Cantor Fitzgerald分析師羅斯·奧斯本對Anteris Technologies Global CORP（納斯達克：AVR）進行了覆蓋，給予了增持評級，並宣佈目標價爲9美元。週一Anteris Technologies股票收於5.61美元。看看其他分析師如何看待這隻股票。
Considering buying KO stock? Here's what analysts think:
考慮購買KO股票嗎？以下是分析師的看法：
Read This Next:
接下來請閱讀：
- Wells Fargo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
- 富國銀行爲第四季度的業績做好準備；以下是華爾街最準確的分析師最近的預測變化
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。